Robert Burger
Gynecologic Oncology · Philadelphia, PANPI 1043393564
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,653 of the $58,866 with a category attached, or 60.6%. Sanofi accounts for 61.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $38,544 and has fallen 74.3% since, to $9,925 in 2021.
Across 74 payments — averaging $795.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$36K
- Tesaro, Inc.$16K
- AstraZeneca$3K
- Myriad Genetic Laboratories, Inc.$2K
- Merck$1K
- Eisai Inc.$692
- plus $519 from 3 others
Across 46 payments — averaging $19,118 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$445K
- Genentech, Inc.$246K
- AstraZeneca$126K
- Regeneron$33K
- Acerta Pharma LLC$30K
- Merck$220
What the payments were for
- Consulting fees$19,21633%
- Speaking & faculty fees$35,65361%
- Travel & lodging$2,2934%
- Food & beverage$1,7043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 24 | $36,319 |
| Tesaro, Inc. | 39 | $15,586 |
| AstraZeneca | 4 | $3,250 |
| Myriad Genetic Laboratories, Inc. | 1 | $1,500 |
| Merck | 1 | $1,000 |
| Eisai Inc. | 1 | $692 |
| Genentech, Inc. | 2 | $472 |
| Roche Products Limited | 1 | $38 |
| Clovis Oncology, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUBAGIO$32,622
- ZEJULA$6,169
- myChoice CDx$1,500
How this compares
$58,866 in reported general payments places this provider in the 85th percentile of 90 gynecologic oncology providers in Pennsylvania.
Other gynecologic oncology in Philadelphia
- Emily KoPhiladelphia$78K
- Anna SmithPhiladelphia$77K
- Stephanie KingPhiladelphia$17K
- Sarah KimPhiladelphia$14K
- Fiona SimpkinsPhiladelphia$11K
- Ashley HaggertyPhiladelphia$8K
- Janos TanyiPhiladelphia$3K
- Lea MoukarzelPhiladelphia$3K
- Charlotte MarcusPhiladelphia$660
- Camille McCallisterPhiladelphia$466
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.